ArticleBiomedical optics express2026
ENDOSWIR clinical proof of concept: a reflectance-based multispectral imaging device for head and neck cancer detection.
Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in Technology and Applications of Optical Sensing and Imaging for Biomedicine: introduction.Biomedical optics express · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Achieving clear surgical margins during head and neck squamous cell carcinoma (HNSCC) procedures is of paramount significance, as it plays a crucial role in mitigating the probability of recurrence and enhancing patient outcomes. The differentiation of tumors from healthy tissue remains a significant challenge, particularly in cases of infiltrative tumors. The integration of multispectral short-wave infrared (SWIR) imaging with machine learning algorithms may enhance the efficacy of tumor detection, particularly in the specific areas of resection margins. In this prospective monocentric study (2022), 10 patients with oral or oropharyngeal squamous cell carcinoma were included. The ENDOSWIR device, a multispectral SWIR imaging system, was utilized in the analysis of freshly resected ex vivo specimens. Reflectance at six wavelengths (975-1575 nm) was recorded. A support vector machine (SVM) algorithm was employed to differentiate between tumoral and healthy tissues. This classification was achieved through the analysis of reflectance absolute values and slope features. Subsequently, a binary mask was applied to the images, utilizing pixel-wise SVM scores. Histopathology served as the gold standard for the diagnosis of these conditions. The primary outcomes encompassed the sensitivity, specificity, and predictive values of ENDOSWIR. Secondary outcomes assessed processing time in comparison to frozen section analysis. Across a total of 494 regions of interest, the SVM algorithm demonstrated a 95% sensitivity and 96% specificity, exhibiting positive and negative predictive values of 95%. On independent test datasets, sensitivity and specificity levels were recorded at 80% and 88%, respectively. The acquisition and analysis of ENDOSWIR samples required a mean time of 3-5 minutes per sample, a significant reduction compared to the approximately 23 minutes required for frozen section analysis. ENDOSWIR exhibited high precision and rapidity in detecting ex vivo tumor tissue, suggesting its potential as a rapid, effective tool to improve surgical precision in HNSCC resections and assist pathologists. Subsequent optimization is necessary for intraoperative utilization.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.